The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD)

Archives of Gerontology and Geriatrics

Volumn 55, Issue 3, 2012, Pages 739-743

  Kuyumcu, Mehmet Emin ^a   Yesil, Yusuf ^a   Oztürk, Zeynel Abidin ^b   Cinar, Esat ^a   Kizilarslanoglu, Cemal ^a   Halil, Meltem ^a   Ulger, Zekeriya ^a   Yesil, Nesibe Karahan ^c   Cankurtaran, Mustafa ^a   Arioĝul, Servet ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Antioxidant; Elderly; Hcy; Osteoporosis; Oxidative stress; Uric acid

Indexed keywords

ALBUMIN; BILIRUBIN; BIOLOGICAL MARKER; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HOMOCYSTEINE; URIC ACID;

AGED; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BONE DENSITOMETRY; BONE DENSITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GERIATRIC ASSESSMENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; UPREGULATION; URIC ACID BLOOD LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GERIATRIC ASSESSMENT; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; OXIDATIVE STRESS; PREVALENCE; SERUM ALBUMIN; SEX FACTORS; URIC ACID;

EID: 84865636718     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2012.05.004     Document Type: Article

References (38)

1. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proceedings of the National Academy of Sciences of the United States of America 1981, 78:6858-6862.
2. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochemical and Biophysical Research Communications 2004, 314:197-207.
3. Bolitho C., Bayl P., Hou J.Y., Lynch G., Hassel A.J., Wall A.J., et al. The anti-apoptotic activity of albumin for endothelium is mediated by a partially cryptic protein domain and reduced by inhibitors of G-coupled protein and PI-3 kinase, but is independent of radical scavenging or bound lipid. Journal of Vascular Research 2007, 44:313-324.
4. Bozkurt N., Erdem M., Yilmaz E., Erdem A., Biri A., Kubatova A., et al. The relationship of homocyteine, B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Archives of Gynecology and Obstetrics 2009, 280:381-387.
5. Cao G., Prior R.L. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clinical Chemistry 1998, 44:1309-1315.
6. Compston J.E., Papapoulos S.E., Blanchard F. Report on osteoporosis in the European Community: Current status and recommendations for the future. Working party from European Union Member States. Osteoporosis International 1998, 8:531-534.
7. Dhonukshe-Rutten R.A., Lips M., de Jong N., Chin A., Paw M.J., Hiddink G.J., et al. Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. Journal of Nutrition 2003, 133:801-807.
8. Dhonukshe-Rutten R.A., van Dusseldorp M., Schneede J., de Groot L.C., van Staveren W.A. Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents. European Journal of Nutrition 2005, 44:341-347.
9. Eisman J., Clapham S., Kehoe L., Study A.B. Osteoporosis prevalence and levels of treatment in primary care: The Australian BoneCare Study. Journal of Bone and Mineral Research 2004, 19:1969-1975.
10. Elshorbagy A.K., Gjesdal C.G., Nurk E., Tell G.S., Ueland P.M., Nygård O., et al. Cysteine, homocysteine and bone mineral density: A role for body composition?. Bone 2009, 44:954-958.
11. Fleming J.T., Barati M.T., Beck D.J., Dodds J.C., Malkani A.L., Parameswaran D., et al. Bone blood flow and vascular reactivity. Cells, Tissues and Organs 2001, 169:279-284.
12. Gabriel S.E., Tosteson A.N., Leibson C.L., Crowson C.S., Pond G.R., Hammond C.S., et al. Direct medical costs attributable to osteoporotic fractures. Osteoporosis International 2002, 13:323-330.
13. Genant H., Cooper C., Poor G., Reid I., Ehrlich G., Kanis J., et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporosis International 1999, 10:259-264.
14. Golbahar J., Hamidi A., Aminzadeh M.A., Omrani G.R. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: A cross-sectional study. Bone 2004, 35:760-765.
15. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence?. Lancet 1994, 344:721-724.
16. Hodgson S.F., Watts N.B., Bilezikian J.P., Clarke B.L., Gray T.K., Harris D.W., et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocrine Practice 2003, 9:544-564.
17. Kanis J.A., Black D., Cooper C., Dargent P., Dawson-Hughes B., De Laet C., et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporosis International 2002, 13:527-536.
18. Kim B.J., Seo M., Huh J.K., Kwon C.H., Kim J.T., Sung K.C., et al. Associations of plasma homocysteine levels with arterial stiffness in prehypertensive individuals. Clinical and Experimental Hypertension 2011, 33:411-417.
19. Kirkby K.A., Adin C.A. Products of heme oxygenase and their potential therapeutic applications. American Journal of Physiology - Renal Physiology 2006, 290:F563-F571.
20. Lean J.M., Davies J.T., Fuller K., Jagger C.J., Kirstein B., Partington G.A., et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. The Journal of Clinical Investigation 2003, 112:915-923.
21. Lean J.M., Jagger C.J., Kirstein B., Fuller K., Chambers T.J. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 2005, 146:728-735.
22. Leboff M.S., Narweker R., LaCroix A., Wu L., Jackson R., Lee J., et al. Homocysteine levels and risk of hip fracture in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism 2009, 94:1207-1213.
23. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., Mecocci P., et al. Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. The Journal of Clinical Endocrinology and Metabolism 2003, 88:1523-1527.
24. Melhus H., Michaëlsson K., Holmberg L., Wolk A., Ljunghall S. Smoking, antioxidant vitamins, and the risk of hip fracture. Journal of Bone and Mineral Research 1999, 14:129-135.
25. Morris M.S., Jacques P.F., Selhub J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 2005, 37:234-242.
26. Mueller G., Russell R.G. Osteoporosis: Pathogenesis and clinical intervention. Biochemical Society Transactions 2003, 31:462-464.
27. Nabipour I., Sambrook P.N., Blyth F.M., Janu M.R., Waite L.M., Naganathan V., et al. Serum uric acid is associated with bone health in older men: A cross-sectional, population-based study. Journal of Bone and Mineral Research 2010.
28. Raisz L.G. Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. The Journal of Clinical Investigation 2005, 115:3318-3325.
29. Reid I., Ames R., Evans M., Sharpe S., Gamble G. Determinants of the rate of bone loss in normal postmenopausal women. The Journal of Clinical Endocrinology and Metabolism 1994, 79:950-954.
30. Sánchez-Rodríguez M.A., Ruiz-Ramos M., Correa-Muñoz E., Mendoza-Núñez V.M. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskeletal Disorders 2007, 8:124.
31. Tenenhouse A., Joseph L., Kreiger N., Poliquin S., Murray T.M., Blondeau L., et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: The Canadian Multicentre Osteoporosis Study (CaMos). Osteoporosis International 2000, 11:897-904.
32. Troen B.R. Molecular mechanisms underlying osteoclast formation and activation. Experimental Gerontology 2003, 38:605-614.
33. Tucker K.L., Hannan M.T., Qiao N., Jacques P.F., Selhub J., Cupples L.A., et al. Low plasma vitamin B12 is associated with lower BMD: The Framingham Osteoporosis Study. Journal of Bone and Mineral Research 2005, 20:152-158.
34. Tyagi N., Kandel M., Munjal C., Qipshidze N., Vacek J.C., Pushpakumar S.B., et al. Homocysteine mediated decrease in bone blood flow and remodeling: Role of folic acid. Journal of Orthopaedic Research 2011, 29:1511-1516.
35. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., van der Klift M., de Jonge R., Lindemans J., et al. Homocysteine levels and the risk of osteoporotic fracture. New England Journal of Medicine 2004, 350:2033-2041.
36. Weiss N., Heydrick S., Zhang Y.Y., Bierl C., Cap A., Loscalzo J. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2002, 22:34-41.
37. Yavuz B.B., Yavuz B., Halil M., Cankurtaran M., Ulger Z., Cankurtaran E.S., et al. Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's disease. International Psychogeriatrics 2008, 20:815-823.
38. Zhang Y.B., Zhong Z.M., Hou G., Jiang H., Chen J.T. Involvement of oxidative stress in age-related bone loss. Journal of Surgical Research 2011, 169:e37-e42.